A big week for mRNA COVID-19 vaccines: Five key developments

A big week for mRNA COVID-19 vaccines: Five key developments

Source: 
Biopharma Reporter
snippet: 

It's been a big week for mRNA-based COVID-19 vaccines: with both Pfizer/BioNTech and Moderna reporting impressive efficacy for their COVID-19 vaccine candidates. Here's five key takeaways from this week's developments.